Company intelligence / Profile preview

EvE Bio

Durham, North Carolina, United Statesevebio.org ↗

Ownership: Private
Employees: ~30
Development stage: Preclinical

Overview

EvE Bio is building an open-source database mapping the interactions between all known small-molecule drugs and human proteins. This resource aims to accelerate early-stage drug discovery, improve safety profiling, enable AI-driven drug development, support polypharmacology research, facilitate animal-free toxicity testing for chemicals, and drive efficient drug repurposing. The project is philanthropically funded with a fixed five-year mission.

Therapeutic areas: Other
Modalities: Small molecule (focus on mapping small-molecule drug interactions)
Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Convergent ResearchDrugBankFounders PledgeLyda Hill Philanthropies

Beyond the preview

Go deeper on EvE Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on EvE Bio.

Explore the full profile